For research use only. Not for therapeutic Use.
Phosphatidylcholine transfer protein inhibitor-1 (Answer 37 in Patent) is a phosphatidylcholine transfer protein (PC-TP) inhibitor. Phosphatidylcholine transfer protein inhibitor-1 can be used for research of PC-TP related disease such as obesity[1].
Catalog Number | I041075 |
CAS Number | 379723-99-6 |
Synonyms | N-[[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]carbamothioyl]-4-fluorobenzamide |
Molecular Formula | C21H17ClFN3O3S2 |
Purity | ≥95% |
InChI | InChI=1S/C21H17ClFN3O3S2/c1-13-5-10-17(24-21(30)25-20(27)14-6-8-16(23)9-7-14)12-19(13)31(28,29)26-18-4-2-3-15(22)11-18/h2-12,26H,1H3,(H2,24,25,27,30) |
InChIKey | NCOKQDHZCJTXLX-UHFFFAOYSA-N |
SMILES | CC1=C(C=C(C=C1)NC(=S)NC(=O)C2=CC=C(C=C2)F)S(=O)(=O)NC3=CC(=CC=C3)Cl |
Reference | [1]. David Cohen, et al. Phosphatidylcholine transfer protein inhibitors. Patent. WO2011022393. |